Scientific research presentations in pharmacoeconomics and health outcomes research

Status of India compared to SAARC and BRICS countries

Sreeranjani Menon, Harshith Nayak, Virendra Ligade

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

South Asian Association for Regional Cooperation (SAARC) and Brazil, Russia, India, China, and South Africa (BRICS) countries' contribution in the field of science and engineering has grown immensely over the decade. BRICS countries have accelerated their efforts in healthcare, as well in the pharmaceutical sector through increased efforts in research and development, acquisitions, and generic drug manufacturing. Pharmacoeconomics and health outcomes research field give an indication about healthcare coverage and access decisions. India being significantly major player among SAARC and BRICS countries in terms of economy and policy making, the present study attempted to analyze scientific research presentation made by India compared to SAARC and BRICS countries in the area of pharmacoeconomics and health outcomes research at International Society for Pharmacoeconomics and Outcomes Research Meetings. The scientific research presentation abstracts published from 2008 to 2017 were included in the study. Research in the area of pharmacoeconomics and health outcomes studies has increased in SAARC and BRICS countries over the last 10 years. The collaborative research with foreign/international authors is also increasing, which is an encouraging trend in this area. The research carried out by SAARC and BRICS countries in the above-said area should be strengthened further which may be beneficial to the society in the coming years.

Original languageEnglish
Pages (from-to)135-140
Number of pages6
JournalJournal of Applied Pharmaceutical Science
Volume9
Issue number2
DOIs
Publication statusPublished - 01-01-2019

Fingerprint

Pharmaceutical Economics
Russia
South Africa
Brazil
India
China
Outcome Assessment (Health Care)
Health
Research
Generic Drugs
Delivery of Health Care
Policy Making

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

@article{4827a304672f4ff4b1ddd2dfe57ea068,
title = "Scientific research presentations in pharmacoeconomics and health outcomes research: Status of India compared to SAARC and BRICS countries",
abstract = "South Asian Association for Regional Cooperation (SAARC) and Brazil, Russia, India, China, and South Africa (BRICS) countries' contribution in the field of science and engineering has grown immensely over the decade. BRICS countries have accelerated their efforts in healthcare, as well in the pharmaceutical sector through increased efforts in research and development, acquisitions, and generic drug manufacturing. Pharmacoeconomics and health outcomes research field give an indication about healthcare coverage and access decisions. India being significantly major player among SAARC and BRICS countries in terms of economy and policy making, the present study attempted to analyze scientific research presentation made by India compared to SAARC and BRICS countries in the area of pharmacoeconomics and health outcomes research at International Society for Pharmacoeconomics and Outcomes Research Meetings. The scientific research presentation abstracts published from 2008 to 2017 were included in the study. Research in the area of pharmacoeconomics and health outcomes studies has increased in SAARC and BRICS countries over the last 10 years. The collaborative research with foreign/international authors is also increasing, which is an encouraging trend in this area. The research carried out by SAARC and BRICS countries in the above-said area should be strengthened further which may be beneficial to the society in the coming years.",
author = "Sreeranjani Menon and Harshith Nayak and Virendra Ligade",
year = "2019",
month = "1",
day = "1",
doi = "10.7324/JAPS.2019.90219",
language = "English",
volume = "9",
pages = "135--140",
journal = "Journal of Applied Pharmaceutical Science",
issn = "2231-3354",
publisher = "MediPoeia",
number = "2",

}

Scientific research presentations in pharmacoeconomics and health outcomes research : Status of India compared to SAARC and BRICS countries. / Menon, Sreeranjani; Nayak, Harshith; Ligade, Virendra.

In: Journal of Applied Pharmaceutical Science, Vol. 9, No. 2, 01.01.2019, p. 135-140.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Scientific research presentations in pharmacoeconomics and health outcomes research

T2 - Status of India compared to SAARC and BRICS countries

AU - Menon, Sreeranjani

AU - Nayak, Harshith

AU - Ligade, Virendra

PY - 2019/1/1

Y1 - 2019/1/1

N2 - South Asian Association for Regional Cooperation (SAARC) and Brazil, Russia, India, China, and South Africa (BRICS) countries' contribution in the field of science and engineering has grown immensely over the decade. BRICS countries have accelerated their efforts in healthcare, as well in the pharmaceutical sector through increased efforts in research and development, acquisitions, and generic drug manufacturing. Pharmacoeconomics and health outcomes research field give an indication about healthcare coverage and access decisions. India being significantly major player among SAARC and BRICS countries in terms of economy and policy making, the present study attempted to analyze scientific research presentation made by India compared to SAARC and BRICS countries in the area of pharmacoeconomics and health outcomes research at International Society for Pharmacoeconomics and Outcomes Research Meetings. The scientific research presentation abstracts published from 2008 to 2017 were included in the study. Research in the area of pharmacoeconomics and health outcomes studies has increased in SAARC and BRICS countries over the last 10 years. The collaborative research with foreign/international authors is also increasing, which is an encouraging trend in this area. The research carried out by SAARC and BRICS countries in the above-said area should be strengthened further which may be beneficial to the society in the coming years.

AB - South Asian Association for Regional Cooperation (SAARC) and Brazil, Russia, India, China, and South Africa (BRICS) countries' contribution in the field of science and engineering has grown immensely over the decade. BRICS countries have accelerated their efforts in healthcare, as well in the pharmaceutical sector through increased efforts in research and development, acquisitions, and generic drug manufacturing. Pharmacoeconomics and health outcomes research field give an indication about healthcare coverage and access decisions. India being significantly major player among SAARC and BRICS countries in terms of economy and policy making, the present study attempted to analyze scientific research presentation made by India compared to SAARC and BRICS countries in the area of pharmacoeconomics and health outcomes research at International Society for Pharmacoeconomics and Outcomes Research Meetings. The scientific research presentation abstracts published from 2008 to 2017 were included in the study. Research in the area of pharmacoeconomics and health outcomes studies has increased in SAARC and BRICS countries over the last 10 years. The collaborative research with foreign/international authors is also increasing, which is an encouraging trend in this area. The research carried out by SAARC and BRICS countries in the above-said area should be strengthened further which may be beneficial to the society in the coming years.

UR - http://www.scopus.com/inward/record.url?scp=85065038909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065038909&partnerID=8YFLogxK

U2 - 10.7324/JAPS.2019.90219

DO - 10.7324/JAPS.2019.90219

M3 - Article

VL - 9

SP - 135

EP - 140

JO - Journal of Applied Pharmaceutical Science

JF - Journal of Applied Pharmaceutical Science

SN - 2231-3354

IS - 2

ER -